Literature DB >> 1596030

Survival after emergency department versus operating room thoracotomy for penetrating cardiac injuries.

D P Blake1, V L Gisbert, A L Ney, H K Helseth, D W Plummer, E Ruiz, M P Bubrick.   

Abstract

The authors undertook a 6-year retrospective review to assess their experience with penetrating cardiac injuries. Special emphasis was placed on identifying patients with and without tamponade and those requiring emergency department (ED) thoracotomy. Forty-eight patients were identified. Overall survival was 64.6 per cent. Thirty-three patients had tamponade, with 20 requiring ED thoracotomy. Fifteen patients did not have tamponade and two of these needed ED thoracotomy. Five patients who had ED thoracotomy were long-term survivors (22.7%). The remaining 26 patients, 13 with tamponade and 13 without, received operating room (OR) thoracotomy and all survived. The data shows that excellent results are possible with OR thoracotomy for penetrating cardiac injuries, with or without tamponade. However, results are not as good when ED thoracotomy is necessary. This may relate to the severity of the injury, the duration of tamponade, or the inability to control cardiac bleeding during thoracotomy in the ED setting. Even though survival is low with ED thoracotomy, it is high enough to continue to support its use in the deteriorating patient with a penetrating cardiac wound.

Entities:  

Mesh:

Year:  1992        PMID: 1596030

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  2 in total

1.  Penetrating cardiac injuries: predictive model for outcomes based on 2016 patients from the National Trauma Data Bank.

Authors:  J A Asensio; O A Ogun; P Petrone; A J Perez-Alonso; M Wagner; R Bertellotti; B Phillips; D L Cornell; A O Udekwu
Journal:  Eur J Trauma Emerg Surg       Date:  2017-06-03       Impact factor: 3.693

2.  Emergent cardiopulmonary bypass in canines with penetrating cardiac wounds caused by gunshot.

Authors:  Jinzhou Zhang; Wen Wang; Wensheng Chen; Hailong Zhu; Jincheng Liu; Guocheng Sun; Qin Cui; Weiyong Liu; Dinghua Yi
Journal:  Emerg Med J       Date:  2007-11       Impact factor: 2.740

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.